As of April 16, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,748 confirmed measles cases across 33 U.S. jurisdictions, with 94% (1,637 cases) tied to 19 new outbreaks this year, mainly in unvaccinated communities in South Carolina, Utah, Texas, Arizona, and Florida. Declining MMR vaccination coverage—down to 92.5% among 2024-2025 kindergartners from 95.2% in 2019-2020, below the 95% herd immunity threshold—drives sustained transmission of this highly contagious paramyxovirus (R0 12-18). Nearly all cases (92%) occur in unvaccinated or unknown status individuals, often linked to imported infections from global hotspots. Weekly CDC surveillance updates, expected imminently, and school-based vaccination pushes could influence trajectories, with summer travel posing escalation risks per historical patterns.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoPrzypadki odry w USA w 2026 roku?
Przypadki odry w USA w 2026 roku?
$7,603,986 Wol.
$7,603,986 Wol.
Dec 31, 2026
↑2k
99%
↑3k
83%
↑4k
50%
↑5k
33%
↑7,5 tys.
14%
↑10k
12%
↑12,5 tys.
9%
$7,603,986 Wol.
$7,603,986 Wol.
Dec 31, 2026
↑2k
$40,123 Wol.
99%
↑3k
$45,679 Wol.
83%
↑4k
$149,110 Wol.
50%
↑5k
$206,578 Wol.
33%
↑7,5 tys.
$160,132 Wol.
14%
↑10k
$6,484,025 Wol.
12%
↑12,5 tys.
$343,575 Wol.
9%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 16, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,748 confirmed measles cases across 33 U.S. jurisdictions, with 94% (1,637 cases) tied to 19 new outbreaks this year, mainly in unvaccinated communities in South Carolina, Utah, Texas, Arizona, and Florida. Declining MMR vaccination coverage—down to 92.5% among 2024-2025 kindergartners from 95.2% in 2019-2020, below the 95% herd immunity threshold—drives sustained transmission of this highly contagious paramyxovirus (R0 12-18). Nearly all cases (92%) occur in unvaccinated or unknown status individuals, often linked to imported infections from global hotspots. Weekly CDC surveillance updates, expected imminently, and school-based vaccination pushes could influence trajectories, with summer travel posing escalation risks per historical patterns.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Dec 1, 2025, 12:56 PM ET
Wolumen
$7,603,986Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 16, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,748 confirmed measles cases across 33 U.S. jurisdictions, with 94% (1,637 cases) tied to 19 new outbreaks this year, mainly in unvaccinated communities in South Carolina, Utah, Texas, Arizona, and Florida. Declining MMR vaccination coverage—down to 92.5% among 2024-2025 kindergartners from 95.2% in 2019-2020, below the 95% herd immunity threshold—drives sustained transmission of this highly contagious paramyxovirus (R0 12-18). Nearly all cases (92%) occur in unvaccinated or unknown status individuals, often linked to imported infections from global hotspots. Weekly CDC surveillance updates, expected imminently, and school-based vaccination pushes could influence trajectories, with summer travel posing escalation risks per historical patterns.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,603,986Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of April 16, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,748 confirmed measles cases across 33 U.S. jurisdictions, with 94% (1,637 cases) tied to 19 new outbreaks this year, mainly in unvaccinated communities in South Carolina, Utah, Texas, Arizona, and Florida. Declining MMR vaccination coverage—down to 92.5% among 2024-2025 kindergartners from 95.2% in 2019-2020, below the 95% herd immunity threshold—drives sustained transmission of this highly contagious paramyxovirus (R0 12-18). Nearly all cases (92%) occur in unvaccinated or unknown status individuals, often linked to imported infections from global hotspots. Weekly CDC surveillance updates, expected imminently, and school-based vaccination pushes could influence trajectories, with summer travel posing escalation risks per historical patterns.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania